202 related articles for article (PubMed ID: 31415377)
21. Vaccination with WT-1 (Wilms' tumor gene-1) peptide and BCG-CWS in melanoma.
Nishioka M; Tanemura A; Nishida S; Nakano A; Tsuboi A; Oji Y; Oka Y; Azuma I; Sugiyama H; Katayama I
Eur J Dermatol; 2012; 22(2):258-9. PubMed ID: 22240317
[No Abstract] [Full Text] [Related]
22. Nanoparticulation of BCG-CWS for application to bladder cancer therapy.
Nakamura T; Fukiage M; Higuchi M; Nakaya A; Yano I; Miyazaki J; Nishiyama H; Akaza H; Ito T; Hosokawa H; Nakayama T; Harashima H
J Control Release; 2014 Feb; 176():44-53. PubMed ID: 24389133
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment.
Alanee S; Sana S; El-Zawahry A; Peabody J; Pearce T; Adams N; Deebajah M; Crabtree J; Delfino K; McVary K; Robinson K; Rao K
World J Urol; 2021 Oct; 39(10):3807-3813. PubMed ID: 33966128
[TBL] [Abstract][Full Text] [Related]
24. Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
Back YW; Choi S; Choi HG; Shin KW; Son YJ; Paik TH; Kim HJ
PLoS One; 2019; 14(3):e0213536. PubMed ID: 30849108
[TBL] [Abstract][Full Text] [Related]
25. Expanding the Potential of Neoantigen Vaccines: Harnessing Bacille Calmette-Guérin Cell-Wall-Based Nanoscale Adjuvants for Enhanced Cancer Immunotherapy.
Liu K; Peng J; Guo Y; Li Y; Qi X; Duan D; Li T; Li J; Niu Y; Han G; Zhao Y
ACS Nano; 2024 May; 18(18):11910-11920. PubMed ID: 38680054
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.
Begum NA; Ishii K; Kurita-Taniguchi M; Tanabe M; Kobayashi M; Moriwaki Y; Matsumoto M; Fukumori Y; Azuma I; Toyoshima K; Seya T
Infect Immun; 2004 Feb; 72(2):937-48. PubMed ID: 14742539
[TBL] [Abstract][Full Text] [Related]
27. BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection.
Kim KH; Lee YT; Park Y; Ko EJ; Jung YJ; Kim YJ; Jo EK; Kang SM
Biomedicines; 2021 May; 9(5):. PubMed ID: 34063125
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional
Da Gama Duarte J; Parakh S; Andrews MC; Woods K; Pasam A; Tutuka C; Ostrouska S; Blackburn JM; Behren A; Cebon J
Front Immunol; 2018; 9():411. PubMed ID: 29552014
[TBL] [Abstract][Full Text] [Related]
29. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
30. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D
Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445
[TBL] [Abstract][Full Text] [Related]
31. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
Gandhi NM; Morales A; Lamm DL
BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
[TBL] [Abstract][Full Text] [Related]
32. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.
Koike Y; Yoo YC; Mitobe M; Oka T; Okuma K; Tono-oka S; Azuma I
Vaccine; 1998 Dec; 16(20):1982-9. PubMed ID: 9796054
[TBL] [Abstract][Full Text] [Related]
33. Does the cell wall skeleton from Bacille Calmette-Guérin directly induce interferon-gamma, independent of interleukin-12?
Hayashi A; Noda A
Jpn J Clin Oncol; 1996 Jun; 26(3):124-7. PubMed ID: 8656550
[TBL] [Abstract][Full Text] [Related]
34. The restoration of suppressed T cell activities induced by 7,12-dimethylbenz[a]anthracene with an anti-tumor immunomodulator, BCG-cell wall skeleton.
Yamashita U; Ikegami R; Hamaoka T
Gan; 1982 Oct; 73(5):783-9. PubMed ID: 6219910
[TBL] [Abstract][Full Text] [Related]
35. A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14.
Rentsch CA; Thalmann GN; Lucca I; Kwiatkowski M; Wirth GJ; Strebel RT; Engeler D; Pedrazzini A; Hüttenbrink C; Schultze-Seemann W; Torpai R; Bubendorf L; Wicki A; Roth B; Bosshard P; Püschel H; Boll DT; Hefermehl L; Roghmann F; Gierth M; Ribi K; Schäfer S; Hayoz S
Eur Urol Oncol; 2022 Apr; 5(2):195-202. PubMed ID: 35012889
[TBL] [Abstract][Full Text] [Related]
36. Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.
Kato T; Bilim V; Yuuki K; Naito S; Yamanobe T; Nagaoka A; Yano I; Akaza H; Tomita Y
Anticancer Res; 2010 Oct; 30(10):4089-96. PubMed ID: 21036724
[TBL] [Abstract][Full Text] [Related]
37. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice.
Akazawa T; Masuda H; Saeki Y; Matsumoto M; Takeda K; Tsujimura K; Kuzushima K; Takahashi T; Azuma I; Akira S; Toyoshima K; Seya T
Cancer Res; 2004 Jan; 64(2):757-64. PubMed ID: 14744795
[TBL] [Abstract][Full Text] [Related]
39. The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma.
Miyazaki J; Nishiyama H; Yano I; Nakaya A; Kohama H; Kawai K; Joraku A; Nakamura T; Harashima H; Akaza H
Anticancer Res; 2011 Jun; 31(6):2065-71. PubMed ID: 21737624
[TBL] [Abstract][Full Text] [Related]
40. Role of bacillus Calmette-Guérin in the treatment of advanced melanoma.
Stewart JH; Levine EA
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1671-6. PubMed ID: 22050015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
